Nautilus Biotechnolgy (NAUT) Financials

$0.96

$0.04 (3.81%)

As on 02-Sep-2026 16:00EDT

Market cap

$115 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.19	--	--	--	--	--
Cost of Revenue	3.56	6.47	6.35	5.71	3.42	2.84
Gross Profit	-3.37	-6.47	-6.35	-5.71	-3.42	-2.84
Operating Expenses	61.04	60.37	75.12	70.45	63.62	47.66
Operating Profit (EBIT)	-62.78	-66.84	-81.48	-76.15	-63.62	-50.50
Other Income	--	--	--	--	-0.12	0.18
Profit before Tax	-56.52	-59.00	-70.78	-63.68	-57.92	-50.32
Provision for Tax	--	--	-70.78	--	5.82	2.61
Profit after Tax (Net Income)	-56.52	-59.00	-70.78	-63.68	-57.92	-50.32
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-57.92	-50.32

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	131.11	156.97	208.73	265.35	314.92	363.58
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	23.83	26.19	26.38	31.09	28.34	29.06
Current Liabilities	8.64	7.95	7.63	9.12	6.79	5.81
Total Liabilities	172.22	191.11	242.74	305.57	350.05	398.45

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	75.95	85.15	109.92	128.73	162.84	49.23
Current Assets	87.63	105.96	132.83	176.84	187.21	349.22
Total Assets	172.22	191.11	242.74	305.57	350.05	398.45
Total Debt*	27.82	30.02	30.48	34.63	30.33	30.03
Net Current Assets	78.99	98.01	125.19	167.72	180.42	343.41

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-50.70	-59.15	-51.71	-45.81	-39.24
Cash Flow from Investing Activities	--	35.22	66.25	-43.74	-25.74	-138.96
Cash from Financing Activities	--	0.21	1.14	0.37	0.56	327.45
Net Cash Inflow / Outflow	--	--	--	--	-70.98	149.24

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.45	-0.47	-0.56	-0.51	-0.46	-0.41
Cash EPS ($)	--	-0.42	-0.51	-0.47	-0.44	-0.38
Adjusted Book Value ($)	--	1.24	1.66	2.12	2.52	2.93
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.40	-0.47	-0.41	-0.37	-0.32
Free Cash Flow per Share ($)	--	-0.41	-0.49	-0.43	-0.39	-0.33

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-27.69	-26.25	-19.74	-15.68	-27.30
ROE (%)	-39.24	-32.27	-29.86	-21.95	-17.07	-30.14
ROA (%)	-28.72	-27.20	-25.82	-19.42	-15.48	-20.81
EBIT Margin (%)	-23,128.95	--	--	--	--	--
Net Margin (%)	-29,747.89	--	--	--	47,478.69	-27,494.54
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-98.02	--	--	--	--	--
EBIT Growth (%)	37.19	16.64	-11.16	-0.28	-26.20	-222.14
Net Profit Growth (%)	13.95	16.64	-11.16	-9.93	-15.12	-222.14
EPS Growth (%)	14.39	0.17	-0.10	-0.10	-0.15	0.18
Book Value Growth (%)	-27.99	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.17	-2.99	-5.87	-3.88	-12.79
Price / Book Value	0.88	1.57	1.01	1.41	0.71	1.77
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.00	-3.29	-1.74	-3.80	-1.17	-6.91
Close Price ($)	1.87	1.95	1.68	2.99	1.80	5.18
High Price ($)	4.31	2.54	3.25	4.65	5.43	25.89
Low Price ($)	0.63	0.63	1.61	1.57	1.50	4.41
Market Cap ($ Cr)	115.05	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.19	0.15	0.13	0.10	0.08
Short term debt to equity ratio	0.03	0.02	0.02	0.01	0.01	0.00
Current Ratio	10.14	13.33	17.40	19.39	27.57	60.09
Quick Ratio	10.14	--	--	--	--	--
Interest Coverage	--	--	--	--	-10.92	-274.95

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	54.52	75.49	93.19	160.12	140.92
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.